| Systematic (IUPAC) name | |
|---|---|
| 1-(4-(Trifluoromethyl)phenyl)piperazine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? (US) |
| Pharmacokinetic data | |
| Bioavailability | Unknown |
| Identifiers | |
| CAS number | 30459-17-7 |
| ATC code | ? |
| PubChem | CID 24887519 |
| ChemSpider | 108602 |
| Synonyms | N-(para-(Trifluoromethyl)phenyl)piperazine, 1-(α,α,α-Trifluoro-p-tolyl)piperazine |
| Chemical data | |
| Formula | C11H13F3N2 |
| Mol. mass | 230.233 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
1-(4-(Trifluoromethyl)phenyl)piperazine (pTFMPP) is a serotonergic releasing agent. It is rarely encountered as a designer drug but is much less common than the "normal" isomer meta-TFMPP.[1]
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)